Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ultrafem(UFEM) great potential-new feminine protection -- Ignore unavailable to you. Want to Upgrade?

To: KM who wrote (269)	5/18/1998 12:37:00 PM
From: Larry Loeb	Read Replies (1) \| Respond to of 272

All: This was filed on Friday (part of new 8-K filing by Ultrafem).: For Further Information, Please Contact: Ultrafem @ 212/921-2070 Dori Reap Tonya Hinch FOR IMMEDIATE RELEASE ULTRAFEM ANNOUNCES DELISTING FROM NASDAQ NEW YORK, NY, MAY 15, 1998 -- Ultrafem, Inc. announced today that subsequent to its April 1, 1998 bankruptcy filing, NASDAQ notified the Company on May 5, 1998 that Ultrafem common stock, which traded under the symbol UFEMQ, was delisted from the Nasdaq National Market. In unrelated matters, Richard Cone resigned from the Board of Directors on April 30, 1998, according to Joy V. Jones, chairperson. The Company also announced that two additional class action lawsuits have been filed against the Company, certain of its officers, directors, and former directors. The Company believes the allegations in these complaints are without merit. These actions are stayed with respect to Ultrafem as a result of the Chapter 11 filing. Ultrafem is a women's health care company. The Company's business strategy is to develop, manufacture and market proprietary products based on its patented SoftCup(R) technology. * * * * -5- Larry